Between February 2024 and October 2025, the number of American adults who reported taking GLP-1s for weight loss more than doubled, constituting roughly 12% of the population, according to Gallup polling
[2] The takeaway for anyone interested in gut health is simple but powerful: because L-cells respond to signals arriving from the gut lumen, the environment inside your intestine including the composition and activity of your microbiome is directly upstream of how much GLP-1 gets made
Does Flow Wellness accept health insurance for medical weight loss programs
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes
HGH influences insulin sensitivity and lipid metabolism, whilst retatrutide modulates appetite hormones and incretin signalling
They are mostly in development or limited-release trials